First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: Apr 28, 2024

Intrinsic Value

VIVO's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. [ Read More ]

The intrinsic value of one VIVO stock under the Base Case scenario is 12.31 USD. Compared to the current market price of 33.97 USD, Meridian Bioscience Inc is Overvalued by 64%.

Key Points:
VIVO Intrinsic Value
Base Case
12.31 USD
Overvaluation 64%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Meridian Bioscience Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling VIVO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Meridian Bioscience Inc

Provide an overview of the primary business activities
of Meridian Bioscience Inc.

What unique competitive advantages
does Meridian Bioscience Inc hold over its rivals?

What risks and challenges
does Meridian Bioscience Inc face in the near future?

Has there been any significant insider trading activity
in Meridian Bioscience Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Meridian Bioscience Inc.

Provide P/S
for Meridian Bioscience Inc.

Provide P/E
for Meridian Bioscience Inc.

Provide P/OCF
for Meridian Bioscience Inc.

Provide P/FCFE
for Meridian Bioscience Inc.

Provide P/B
for Meridian Bioscience Inc.

Provide EV/S
for Meridian Bioscience Inc.

Provide EV/GP
for Meridian Bioscience Inc.

Provide EV/EBITDA
for Meridian Bioscience Inc.

Provide EV/EBIT
for Meridian Bioscience Inc.

Provide EV/OCF
for Meridian Bioscience Inc.

Provide EV/FCFF
for Meridian Bioscience Inc.

Provide EV/IC
for Meridian Bioscience Inc.

Show me price targets
for Meridian Bioscience Inc made by professional analysts.

What are the Revenue projections
for Meridian Bioscience Inc?

How accurate were the past Revenue estimates
for Meridian Bioscience Inc?

What are the Net Income projections
for Meridian Bioscience Inc?

How accurate were the past Net Income estimates
for Meridian Bioscience Inc?

What are the EPS projections
for Meridian Bioscience Inc?

How accurate were the past EPS estimates
for Meridian Bioscience Inc?

What are the EBIT projections
for Meridian Bioscience Inc?

How accurate were the past EBIT estimates
for Meridian Bioscience Inc?

Compare the revenue forecasts
for Meridian Bioscience Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Meridian Bioscience Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Meridian Bioscience Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Meridian Bioscience Inc compared to its peers.

Compare the P/E ratios
of Meridian Bioscience Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Meridian Bioscience Inc with its peers.

Analyze the financial leverage
of Meridian Bioscience Inc compared to its main competitors.

Show all profitability ratios
for Meridian Bioscience Inc.

Provide ROE
for Meridian Bioscience Inc.

Provide ROA
for Meridian Bioscience Inc.

Provide ROIC
for Meridian Bioscience Inc.

Provide ROCE
for Meridian Bioscience Inc.

Provide Gross Margin
for Meridian Bioscience Inc.

Provide Operating Margin
for Meridian Bioscience Inc.

Provide Net Margin
for Meridian Bioscience Inc.

Provide FCF Margin
for Meridian Bioscience Inc.

Show all solvency ratios
for Meridian Bioscience Inc.

Provide D/E Ratio
for Meridian Bioscience Inc.

Provide D/A Ratio
for Meridian Bioscience Inc.

Provide Interest Coverage Ratio
for Meridian Bioscience Inc.

Provide Altman Z-Score Ratio
for Meridian Bioscience Inc.

Provide Quick Ratio
for Meridian Bioscience Inc.

Provide Current Ratio
for Meridian Bioscience Inc.

Provide Cash Ratio
for Meridian Bioscience Inc.

What is the historical Revenue growth
over the last 5 years for Meridian Bioscience Inc?

What is the historical Net Income growth
over the last 5 years for Meridian Bioscience Inc?

What is the current Free Cash Flow
of Meridian Bioscience Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Meridian Bioscience Inc.

Financials

Balance Sheet Decomposition
Meridian Bioscience Inc

Current Assets 210.6m
Cash & Short-Term Investments 81.5m
Receivables 47.2m
Other Current Assets 81.9m
Non-Current Assets 252.5m
PP&E 50.7m
Intangibles 190.4m
Other Non-Current Assets 11.4m
Current Liabilities 58m
Accounts Payable 17.8m
Accrued Liabilities 25.7m
Other Current Liabilities 14.5m
Non-Current Liabilities 37.1m
Long-Term Debt 25m
Other Non-Current Liabilities 12.1m
Efficiency

Earnings Waterfall
Meridian Bioscience Inc

Revenue
333m USD
Cost of Revenue
-144.7m USD
Gross Profit
188.4m USD
Operating Expenses
-112.8m USD
Operating Income
75.6m USD
Other Expenses
-33.1m USD
Net Income
42.5m USD

Free Cash Flow Analysis
Meridian Bioscience Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

VIVO Profitability Score
Profitability Due Diligence

Meridian Bioscience Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROE
59/100
Profitability
Score

Meridian Bioscience Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

VIVO Solvency Score
Solvency Due Diligence

Meridian Bioscience Inc's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Low D/E
97/100
Solvency
Score

Meridian Bioscience Inc's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VIVO Price Targets Summary
Meridian Bioscience Inc

There are no price targets for VIVO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

VIVO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

VIVO Price
Meridian Bioscience Inc

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
+64%
5Y 5Y
+153%
10Y 10Y
+104%
Annual Price Range
33.97
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return 27.26%
Standard Deviation of Annual Returns 69.87%
Max Drawdown -59%
Shares Statistics
Market Capitalization 1.5B USD
Shares Outstanding 43 827 800
Percentage of Shares Shorted 13.51%

VIVO Return Decomposition
Main factors of price return

What is price return decomposition?

VIVO News

Other Videos

Company Profile

Meridian Bioscience Inc Logo
Meridian Bioscience Inc

Country

United States of America

Industry

Health Care

Market Cap

1.5B USD

Dividend Yield

0%

Description

Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. The company is headquartered in Cincinnati, Ohio and currently employs 765 full-time employees. The firm is engaged in the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain gastrointestinal and respiratory infectious diseases and elevated blood lead levels. The firm's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi' in, Israel. The segment also includes blood chemistry products in Billerica, Massachusetts and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; and Luckenwalde, Germany; and the sale and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, and bioresearch reagents domestically and abroad.

Contact

OHIO
Cincinnati
3471 River Hills Dr
+15132713700.0
http://www.meridianbioscience.com/

IPO

1986-07-29

Employees

765

Officers

Pres, CEO & Director
Mr. John P. Kenny
Exec. VP of Life Science Bus. Unit
Dr. Lourdes G. Weltzien Ph.D.
Exec. VP of Diagnostics
Mr. Tony Serafini-Lamanna
Exec. VP & CFO
Mr. Andrew S. Kitzmiller
Sr. VP, Controller & Principal Accounting Officer
Ms. Julie Smith
Director of Corp. Fin.
Mr. Jeff Pinkston
Show More
VP of Corp. Strategy, Bus. Devel. & Investor Relations
Mr. Charles Wood
Sr. VP & Gen. Counsel
Mr. Emerson C. Moser
VP of Global HR
Ms. Melissa J. McCarey
Consultant
Ms. Susan D. Rolih
Show Less

See Also

Discover More
What is the Intrinsic Value of one VIVO stock?

The intrinsic value of one VIVO stock under the Base Case scenario is 12.31 USD.

Is VIVO stock undervalued or overvalued?

Compared to the current market price of 33.97 USD, Meridian Bioscience Inc is Overvalued by 64%.